Evelyn Pau joined Amplitude as a Principal in August 2024. She works directly with Amplitude’s portfolio companies while supporting the deal team on active diligence and nomination.
Prior to joining Amplitude, Evelyn was the Vice President, Investment Banking at Bloom Burton & Co., a healthcare-focused investment banking firm. At Bloom Burton, her responsibilities included deal origination, strategic advisory, and venture creation for pharmaceutical, biotechnology, and healthcare companies. Previous to that, Evelyn was a Business Development Analyst at Tornado Medical Systems (acquired by Bruker) and a Research Fellow at SECOR Consulting (acquired by KPMG). She completed her PhD in immunology at the University of Toronto, specializing in the genetics of lupus, and her BMSc (Hons) in microbiology and immunology at Western University.